These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 27163335

  • 1. Adenovirus-mediated artificial microRNA against human fibrinogen like protein 2 inhibits hepatocellular carcinoma growth.
    Wang M, Liu J, Xi D, Luo X, Ning Q.
    J Gene Med; 2016 Jul; 18(7):102-11. PubMed ID: 27163335
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis.
    Liu Y, Xu L, Zeng Q, Wang J, Wang M, Xi D, Wang X, Yang D, Luo X, Ning Q.
    Liver Int; 2012 Nov; 32(10):1585-95. PubMed ID: 22925132
    [Abstract] [Full Text] [Related]

  • 3. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma.
    Su K, Chen F, Yan WM, Zeng QL, Xu L, Xi D, Pi B, Luo XP, Ning Q.
    World J Gastroenterol; 2008 Oct 21; 14(39):5980-9. PubMed ID: 18932275
    [Abstract] [Full Text] [Related]

  • 4. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
    Mao C, Liu H, Chen P, Ye J, Teng L, Jia Z, Cao J.
    Oncotarget; 2015 Mar 20; 6(8):5707-19. PubMed ID: 25691059
    [Abstract] [Full Text] [Related]

  • 5. An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma.
    Li X, Su Y, Sun B, Ji W, Peng Z, Xu Y, Wu M, Su C.
    Mol Cancer Ther; 2016 Jul 20; 15(7):1436-51. PubMed ID: 27196772
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ, Wei W, Guo ZX, Zhang MY, Zhang YF, Wang JH, Shi M, Wang HY, Guo RP.
    J Cancer Res Clin Oncol; 2017 Feb 20; 143(2):263-273. PubMed ID: 27704267
    [Abstract] [Full Text] [Related]

  • 7. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC, Cao X, Gui JH, Zhou XM, Zhong D, Yan QL, Huang WD, Qian QJ, Zhao FL, Liu XY.
    Hum Gene Ther; 2011 Sep 20; 22(9):1109-19. PubMed ID: 21361790
    [Abstract] [Full Text] [Related]

  • 8. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X, Wang Y, Tao J, Shi Y, Gai X, Huang F, Ma Q, Zhou Z, Chen H, Zhang H, Liu Z, Sun Q, Peng H, Chen R, Jing Y, Yang H, Mao Y, Zhang H.
    Gastroenterology; 2015 Sep 20; 149(3):741-52.e14. PubMed ID: 25980751
    [Abstract] [Full Text] [Related]

  • 9. Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models.
    Hu H, Qiu Y, Guo M, Huang Y, Fang L, Peng Z, Ji W, Xu Y, Shen S, Yan Y, Huang X, Zheng J, Su C.
    Oncotarget; 2015 Jan 20; 6(2):1079-89. PubMed ID: 25473902
    [Abstract] [Full Text] [Related]

  • 10. Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.
    Yuan X, Zhang Q, Li Z, Zhang X, Bao S, Fan D, Ru Y, Dong S, Zhang Y, Zhang Y, Ye Z, Xiong D.
    Cancer Lett; 2016 Oct 10; 381(1):85-95. PubMed ID: 27450327
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
    Zhu M, Li M, Wang T, Linghu E, Wu B.
    Tumour Biol; 2016 Oct 10; 37(10):13995-14008. PubMed ID: 27492460
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G, Wang T, Huang QK, Pu M, Sun W, Zhang ZC, Ling R, Tao KS.
    World J Gastroenterol; 2016 Jun 21; 22(23):5364-73. PubMed ID: 27340352
    [Abstract] [Full Text] [Related]

  • 13. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
    Park MY, Park YS, Nam JH.
    Int J Oncol; 2011 Oct 21; 39(4):853-61. PubMed ID: 21701774
    [Abstract] [Full Text] [Related]

  • 14. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
    Liu X, Xu J, Wang S, Yu X, Kou B, Chai M, Zang Y, Chen D.
    Int J Oncol; 2017 Oct 21; 51(4):1291-1299. PubMed ID: 28902369
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
    He J, Zhao K, Zheng L, Xu Z, Gong W, Chen S, Shen X, Huang G, Gao M, Zeng Y, Zhang Y, He F.
    Mol Cancer; 2015 Aug 25; 14():163. PubMed ID: 26302777
    [Abstract] [Full Text] [Related]

  • 16. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
    El-Shemi AG, Ashshi AM, Na Y, Li Y, Basalamah M, Al-Allaf FA, Oh E, Jung BK, Yun CO.
    J Exp Clin Cancer Res; 2016 May 06; 35():74. PubMed ID: 27154307
    [Abstract] [Full Text] [Related]

  • 17. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J, Lai W, Li Q, Yu Y, Jin J, Guo W, Zhou X, Liu X, Wang Y.
    Biochem Biophys Res Commun; 2017 Sep 16; 491(2):469-477. PubMed ID: 28698142
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX, Xia YH, Xue TC, Zhang H, Ye SL.
    Oncol Rep; 2011 Mar 16; 25(3):803-8. PubMed ID: 21174062
    [Abstract] [Full Text] [Related]

  • 19. The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy.
    Lin L, Zhang YD, Chen ZY, Chen Y, Ren CP.
    Tumour Biol; 2016 Sep 16; 37(9):12339-12346. PubMed ID: 27300349
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, Feng ZQ, Zhang JP.
    Chin Med J (Engl); 2011 Nov 16; 124(22):3794-9. PubMed ID: 22340243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.